XML 41 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
 3 Months Ended 9 Months Ended
Sep. 30, 2024
shares
Sep. 30, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Paul J. Clancy [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Paul J. Clancy, a member of our Board of Directors, adopted a trading plan on August 20, 2024 providing for the sale of up to an aggregate of 45,000 shares of our common stock until August 20, 2025.
Name Paul J. Clancy  
Title member of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 20, 2024  
Expiration Date August 20, 2025  
Arrangement Duration 365 days  
Aggregate Available 45,000 45,000
Steven Stein [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Steven Stein, our Executive Vice President and Chief Medical Officer, adopted a trading plan on August 29, 2024 providing for the sale of up to an aggregate of 29,745 shares of our common stock until August 29, 2025.
Name Steven Stein  
Title Executive Vice President and Chief Medical Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 29, 2024  
Expiration Date August 29, 2025  
Arrangement Duration 365 days  
Aggregate Available 29,745 29,745
Vijay Iyengar [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Vijay Iyengar, our Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy, adopted a trading plan on August 29, 2024 providing for the sale of up to an aggregate of 77,316 shares of our common stock until August 29, 2025.
Name Vijay Iyengar  
Title Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 29, 2024  
Expiration Date August 29, 2025  
Arrangement Duration 365 days  
Aggregate Available 77,316 77,316
Thomas Tray [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Thomas Tray, our Vice President, Chief Accounting Officer, adopted a trading plan on September 13, 2024 providing for the sale of up to an aggregate of 1,300 shares of our common stock until September 15, 2025.
Name Thomas Tray  
Title Vice President, Chief Accounting Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date September 13, 2024  
Expiration Date September 15, 2025  
Arrangement Duration 367 days  
Aggregate Available 1,300 1,300